Crossmark

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2− advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)

Crossref DOI link: https://doi.org/10.1007/s12282-025-01787-3

Published Online: 2026-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagai, Shigenori E. https://orcid.org/0000-0003-2887-6066
Hattori, Masaya

Yoshinami, Tetsuhiro

Masuda, Hiroko

Okamura, Takuho

Watanabe, Kenichi

Nakayama, Takahiro

Tsuneizumi, Michiko

Takabatake, Daisuke

Harao, Michiko

Yoshino, Hiroshi

Mori, Natsuko

Yasojima, Hiroyuki

Oshiro, Chiya

Iwase, Madoka

Yamaguchi, Miki

Sangai, Takafumi

Sasada, Shinsuke

Ishida, Takanori

Futamura, Manabu

Muramatsu, Yasuaki

Kosaka, Nobuyoshi https://orcid.org/0000-0001-5571-261X
Masuda, Norikazu https://orcid.org/0000-0002-7302-0278
License Information

Text and Data Mining valid from 2026-01-27

Version of Record valid from 2026-01-27
More Information

Article History

First Online: 27 January 2026

Document is current

Any future updates will be listed below